Manila Bulletin
FDA to come up with new guidance on use of AstraZeneca vaccines this week
The Food and Drug Administration (FDA) will release new guidance on the AstraZeneca vaccine this week following a temporary suspension for those under 60 due to concerns about rare blood clots.
FDA Director General Eric Domingo stated that the new guidance will be finalized within the week.
Domingo mentioned that the FDA is anticipating a new shipment of the AstraZeneca vaccine.
The second dose of the AstraZeneca vaccine will be administered between eight to 12 weeks after the first dose.
The suspension of AstraZeneca vaccinations is seen as a timely measure to allow for the development of new guidelines for vaccinators while awaiting further deliveries.
The Department of Health has not reported any instances of blood clots or low platelet counts among recipients of the AstraZeneca vaccine in the Philippines.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Food and Drug Administration (FDA) is expected to release new guidelines this week for the administration of the AstraZeneca COVID-19 vaccine.
Read more →
The Philippines has temporarily suspended the use of AstraZeneca's COVID-19 vaccine for individuals under 60 years old as a precautionary measure due to rare reports of blood clots with low platelet counts overseas, primarily observed in women under 60.
+2
Read more →